Ann: March 2021 Quarterly Report and Appendix 4C, page-24

I don't think VET is the high growth area you seem to think it is. These are established mature businesses being acquired, not high growth startups. The benefit is more around reducing a shared cost base than growth upside, and of course cross selling. Which is the companies stated main reason fo the strategy.

Its a nice margin, but not where exponential SaaS growth is to be found, which is what I imagine most investors in this stock are after. The real value proposition is in the scalable SaaS platform.

IMO, DYOR

MJ